Become a Franchise Trade Now BA Connect Open an Account Reactivation KYC Modification DP Login
Hot Pursuit
Prev Next
As on Aug 02, 2021 12:00 AM Your results on : Hot Pursuit    
Dr. Lal PathLabs resumes uptrend; adds over 61% this year
02-Aug-2021 (17:31)

The stock had declined by 4.77% to closed at 3,554.55 on Friday (30 July 2021).

On a year-to-date (YTD) basis, the stock has zoomed 61.05% while the benchmark Sensex has added 10.89% during the same period.

Dr. Lal PathLabs had announced its earnings for the quarter ended 30 June 2021 during market hours on Friday.

The diagnostic services provider reported 370.4% jump in consolidated net profit to Rs 133.7 crore in Q1 FY22 from Rs 28.4 crore in Q1 FY21.

Revenue increased by 128.1% YoY to Rs 606.6 crore during the quarter. As compared with Q4 FY21, the company's net profit and revenues have increased by 57.1% and 40.7%, respectively.

Normalised EBITDA increased by 268.7% to Rs 199 crore in Q1 FY22 from Rs 54 crore in Q1 FY21. Normalised margins were at 32.8% as on 30 June 2021 as against 20.3% as on 30 June 2020.

Profit before tax in Q1 FY22 stood at Rs 179.3 crore, up by 370% from Rs 38.1 crore in Q1 FY21.

Interim dividend of Rs 6 per equity share has been approved by the board of the company.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services. As on 31 March 2021 the company has 231 clinical laboratories, 3,705 patient service centers (PSCs) and 9,247 pickup points (PUPs).

SML Isuzu July 2021 total sales grew 79% to 551 units
02-Aug-2021 (17:33)
NMDC July 2021 production gallops 40% to 3.06 MT
02-Aug-2021 (17:05)
Coal India July 2021 production nos. jump 14% to 42 million tonnes
02-Aug-2021 (15:30)
Cholamandalam Investment and Finance Q1 PAT down 24% YoY
02-Aug-2021 (15:23)
IDFC First Bank declines after dismal Q1 earnings
02-Aug-2021 (15:01)
Unichem Laboratories Ltd leads losers in 'A' group
02-Aug-2021 (15:00)
Ind-Swift Laboratories Ltd leads losers in 'B' group
02-Aug-2021 (14:45)
Emami Q1 PAT up over 96% YoY to Rs 77.79 crore
02-Aug-2021 (14:46)
Volumes jump at Bliss GVS Pharma Ltd counter
02-Aug-2021 (14:30)
Ramkrishna Forgings soars after bagging multi-year order from multinational tier-1 OEM
02-Aug-2021 (14:00)
Varun Beverages gains after Q2 PAT rises 123% YoY
02-Aug-2021 (13:45)
Colgate-Palmolive (India) Ltd down for fifth straight session
02-Aug-2021 (13:35)
Bank of India continues to move higher
02-Aug-2021 (13:05)
Canara Bank spurts 1.44%, gains for third straight session
02-Aug-2021 (13:05)
National Aluminium Company Ltd up for third straight session
02-Aug-2021 (13:05)
United Spirits Ltd sees good buying
02-Aug-2021 (13:05)
Oil & Natural Gas Corpn Ltd rises for third consecutive session
02-Aug-2021 (13:05)
Tata Power Company Ltd jumps nearly 3%
02-Aug-2021 (13:05)
Ashok Leyland Ltd in demand
02-Aug-2021 (13:05)
Connect with us :   
Globe
About us
Our Services
Milestones
Memberships
Core Values
Investor Relations
Product & Services
Broking
Institutional Broking
PMS
Clearing Services
Distribution
Research
Depository
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Mobile App Demo
ODIN User Manual
Client Reactivation
Segment activation
Back Office
Back Office
CMS
CMS-TM
KYC/KDC Status
Mutual Fund
CAMS
RMS Policy
Helpdesk
Download Forms
Useful Links
BSE
NSE
SEBI
RBI
MCX
NCDEX
Exchange Holidays
Exchange guidelines on margin collection
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD
Additional Policy and Procedures
Scores

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances please write to
Investor_trading@globecapital.com /  igr@globecapital.com (For Trading)     globedp@globecapital.com (For DP)    Investor_pms@globecapital.com (For PMS)     
commigr@globecapital.com (For Commodities)
Equity SEBI Registration No INZ000177137, Exchange Registration Nos : NSE TM Code - 06637, Clearing No.- M50302|BSE Clearing No: 3179|MSEI TM Code - 1004 ,Clearing No.- 4| MCX TM No: 8091,Clearing No: 8090 | NCDEX TM No:1287, Clearing No: -M51085|ICEX TM ID-2084 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No :INH100001187 | SEBI PMS Registration No:INP000002361 CMBPID NCL CM :- IN555502
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions